COVID-19 and the heart

Roman Roy; Benedict McDonaugh; Kevin O'Gallagher

doi:10.1093/bmb/ldac022

COVID-19 and the heart

Roman Roy, Benedict McDonaugh, Kevin O'Gallagher

SCMMS Denmark Hill

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system. Published literature. Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit. Vaccination as a cause of myocarditis remains a key area of contention. As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk. Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated. [Abstract copyright: © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].]

Original language	English
Pages (from-to)	ldac022
Journal	British medical bulletin
Early online date	24 Sept 2022
DOIs	https://doi.org/10.1093/bmb/ldac022
Publication status	E-pub ahead of print - 24 Sept 2022

Keywords

COVID
myocarditis
COVID-19
heart
SARS-CoV-2
long Covid

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bmb/ldac022

Cite this

@article{35d8d3df670f4fec8b8a34070af82844,

title = "COVID-19 and the heart",

abstract = "There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system. Published literature. Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit. Vaccination as a cause of myocarditis remains a key area of contention. As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk. Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated. [Abstract copyright: {\textcopyright} The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].]",

keywords = "COVID, myocarditis, COVID-19, heart, SARS-CoV-2, long Covid",

author = "Roman Roy and Benedict McDonaugh and Kevin O'Gallagher",

year = "2022",

month = sep,

day = "24",

doi = "10.1093/bmb/ldac022",

language = "English",

pages = "ldac022",

journal = "British medical bulletin",

issn = "0007-1420",

publisher = "Oxford University Press (OUP)",

}

TY - JOUR

T1 - COVID-19 and the heart

AU - Roy, Roman

AU - McDonaugh, Benedict

AU - O'Gallagher, Kevin

PY - 2022/9/24

Y1 - 2022/9/24

N2 - There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system. Published literature. Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit. Vaccination as a cause of myocarditis remains a key area of contention. As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk. Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated. [Abstract copyright: © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].]

AB - There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system. Published literature. Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit. Vaccination as a cause of myocarditis remains a key area of contention. As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk. Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated. [Abstract copyright: © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].]

KW - COVID

KW - myocarditis

KW - COVID-19

KW - heart

KW - SARS-CoV-2

KW - long Covid

U2 - 10.1093/bmb/ldac022

DO - 10.1093/bmb/ldac022

M3 - Article

C2 - 36155748

SN - 0007-1420

SP - ldac022

JO - British medical bulletin

JF - British medical bulletin

ER -

COVID-19 and the heart

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this